Free Trial

Information Stocks List

This page shows information about the 8 largest information sector stocks including NortonLifeLock, Vonage, Cinedigm, and Brooklyn ImmunoTherapeutics.

NortonLifeLock logo

#1 - NortonLifeLock

NASDAQ:NLOK - See Stock Forecast
Stock Price:
$29.11 (+$2.20)
Market Cap:
$16.63 billion
P/E Ratio:
20.4
Dividend Yield:
2.31%
Consensus Rating:
N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target:
N/A
Gen Digital, Inc. engages in the provision of security, storage, and systems management solutions. The firm focuses on providing consumer cyber safety with its business solutions. The company was founded by Gary Hendrix in April 1982 and is headquartered in Tempe, AZ.
Vonage logo

#2 - Vonage

NYSE:VG - See Stock Forecast
Stock Price:
$20.99
Market Cap:
$5.39 billion
Consensus Rating:
N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target:
N/A
Vonage, a global cloud communications leader, helps businesses accelerate their digital transformation. Vonage's Communications Platform is fully programmable and allows for the integration of Video, Voice, Chat, Messaging and Verification into existing products, workflows and systems. Vonage's fully programmable unified communications and contact center applications are built from the Vonage platform and enable companies to transform how they communicate and operate from the office or anywhere, providing enormous flexibility and ensuring business continuity.
Cinedigm logo

#3 - Cinedigm

NASDAQ:CIDM - See Stock Forecast
Stock Price:
$2.47 (-$0.05)
Market Cap:
$461.68 million
Consensus Rating:
N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target:
N/A
Cineverse Corp. is a global streaming technology and entertainment company. It owns and operates streaming channels, all powered by its advanced, proprietary technology platform. The firm currently features enthusiast brands for subscription video on demand (SVOD), advertising-based video on demand (AVOD), and free, ad-supported streaming television (FAST) channels. It entertains consumers around the globe by providing premium feature films and television series, enthusiast streaming channels, and technology services to some media, retail, and technology companies. The company was founded by A. Dale Mayo on March 31, 2000 and is headquartered in New York, NY.
Brooklyn ImmunoTherapeutics logo

#4 - Brooklyn ImmunoTherapeutics

NYSE:BTX - See Stock Forecast
Stock Price:
$1.04 (-$0.05)
Market Cap:
$61.18 million
Consensus Rating:
N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target:
N/A
Eterna Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in creating transformative regenerative medicine treatments for cancer, blood disorders, and monogenic diseases. It offers IRX-2, a human cell-derived cytokine therapy, studying the safety and efficacy of IRX-2 in patients with head and neck cancer in Phase 2B. The company is headquartered in San Diego, CA.
Alfi logo

#5 - Alfi

NASDAQ:ALFIW - See Stock Forecast
Stock Price:
$0.00
Consensus Rating:
N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target:
N/A
Alfi, Inc. provides interactive intelligent artificial intelligence and machine learning software solutions. Alfi, Inc. was formerly known as Lectrefy, Inc. and changed its name to Alfi, Inc. in January 2020. The company was founded in 2018 and is based in Miami Beach, Florida.
Duck Creek Technologies logo

#6 - Duck Creek Technologies

NYSE:DCT - See Stock Forecast
Stock Price:
$18.99
Consensus Rating:
N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target:
N/A
Duck Creek Technologies develops industry-specific software that helps insurance carriers to deploy and manage their products and services.

#7 - Health Assurance Acquisition

NASDAQ:HAACW - See Stock Forecast
Stock Price:
$0.01
Consensus Rating:
N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target:
N/A

#8 - Wytec International

NASDAQ:WYTC - See Stock Forecast
Stock Price:
$2.51 (+$0.18)
Consensus Rating:
N/A (0 Strong Buy Ratings, 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target:
N/A

More Stock Ideas from MarketBeat